Endothelial dysfunction and vascular disease–a 30th anniversary update

PM Vanhoutte, H Shimokawa, M Feletou… - Acta …, 2017 - Wiley Online Library
The endothelium can evoke relaxations of the underlying vascular smooth muscle, by
releasing vasodilator substances. The best‐characterized endothelium‐derived relaxing …

[HTML][HTML] Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targets

F Jiang, J Yang, Y Zhang, M Dong, S Wang… - Nature Reviews …, 2014 - nature.com
The renin–angiotensin system (RAS) has pivotal roles in the regulation of normal physiology
and the pathogenesis of cardiovascular disease. Angiotensin-converting enzyme (ACE) 2 …

[HTML][HTML] Plasma ACE2 predicts outcome of COVID-19 in hospitalized patients

TW Kragstrup, HS Singh, I Grundberg, ALL Nielsen… - PloS one, 2021 - journals.plos.org
Aims Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binds to angiotensin
converting enzyme 2 (ACE2) enabling entrance of the virus into cells and causing the …

Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?

MC Chappell - American Journal of Physiology-Heart and …, 2016 - journals.physiology.org
The renin-angiotensin system (RAS) constitutes a key hormonal system in the physiological
regulation of blood pressure through peripheral and central mechanisms. Indeed …

[HTML][HTML] Update on the angiotensin converting enzyme 2-angiotensin (1–7)-Mas receptor axis: fetal programing, sex differences, and intracellular pathways

MC Chappell, AC Marshall, EM Alzayadneh… - Frontiers in …, 2014 - frontiersin.org
The renin-angiotensin-system (RAS) constitutes an important hormonal system in the
physiological regulation of blood pressure. Indeed, dysregulation of the RAS may lead to the …

Fetal programming and the angiotensin-(1-7) axis: a review of the experimental and clinical data

AM South, HA Shaltout, LK Washburn… - Clinical …, 2019 - portlandpress.com
Hypertension is the primary risk factor for cardiovascular disease that constitutes a serious
worldwide health concern and a significant healthcare burden. As the majority of …

Angiotensin-converting enzyme 2 and COVID-19: patients, comorbidities, and therapies

G Pathangey, PP Fadadu… - American Journal of …, 2021 - journals.physiology.org
On March 11, 2020, the World Health Organization declared coronavirus disease 2019
(COVID-19) a pandemic, and the reality of the situation has finally caught up to the …

Circulating ACE2 in cardiovascular and kidney diseases

L Anguiano, M Riera, J Pascual… - Current medicinal …, 2017 - ingentaconnect.com
Angiotensin converting enzyme (ACE) 2 is a homologue of ACE that catalyzes the
conversion of Angiotensin (Ang) II into Ang1-7, which induces vasodilation, anti-fibrotic, anti …

[HTML][HTML] ACE2: angiotensin II/angiotensin-(1–7) balance in cardiac and renal injury

J Varagic, S Ahmad, S Nagata, CM Ferrario - Current hypertension reports, 2014 - Springer
Our current recognition of the renin-angiotensin system is more convoluted than originally
thought due to the discovery of multiple novel enzymes, peptides, and receptors inherent in …

ACE2 alterations in kidney disease

MJ Soler, J Wysocki, D Batlle - Nephrology dialysis …, 2013 - academic.oup.com
Abstract Angiotensin-converting enzyme 2 (ACE2) is a monocarboxypeptidase that
degrades angiotensin (Ang) II to Ang-(1–7). ACE2 is highly expressed within the kidneys, it …